Research and development expense

Name: Avalo Therapeutics Research and development expense by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Avalo Therapeutics·Business Segments·1 segment·Rolls up to R&D

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	$9.12M	$14.07M	$13.62M	$13.27M	$14.05M
Total	$9.12M	$14.07M	$13.62M	$13.27M	$14.05M

Segments

Business SegmentsView metric